USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
SCR, INC.
Address:
620 South Third Street
LOUISVILLE, KY
Phone:
N/A
URL:
N/A
EIN:
611360281
DUNS:
610420817
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $680,066.00 3
SBIR Phase II $4,601,227.00 3

Award List:

A counterpulsation device to promote myocardial recovery

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$172,749.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The incidence of congestive heart failure (CHF) is increasing worldwide with over one million new cases diagnosed annually. Over the past 30 years, counterpulsation with an intra-aortic balloon pump (IABP) has been widely and successfully used as a short-term… More

Portable pneumatic driver for counterpulsation therapy

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$268,790.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The incidence of congestive heart failure (CHF) is increasing worldwide with over one million new cases diagnosed annually. Over the past 30 years, counterpulsation with an intra-aortic balloon pump (IABP) has been wide ly and successfully used as a short-term… More

Development of a Counterpulsation Therapy Device

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$1,437,630.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): SCR, Inc. (Louisville, KY) has developed a long-term implantable counterpulsation device (CPD) to treat heart failure (HF) patients who may be responsive to a milder form of cardiac assist. The CPD is 32-ml stroke vol ume, valveless pneumatically-driven blood… More

Portable pneumatic driver for counterpulsation therapy

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$1,580,460.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): SCR, Inc. (Louisville, KY) is developing a chronic implantable CPD system to treat HF patients who may be responsive to long-term counterpulsation support. The CPD has been developed for superficial implantation via a p acemaker incision without the need to enter… More

Counterpulsation Device with Integrated ECG Sensing

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$238,527.00
Agency:
HHS
Principal Investigator:
Robert D. Dowling
Abstract:
DESCRIPTION (provided by applicant): Counterpulsation with an intra-aortic balloon pump has been widely and successfully used as a short term treatment for both acute and chronic cardiac dysfunction. SCR (Louisville, KY) is developing a novel chronic, imp lantable counterpulsation device (CPD) to… More

Counterpulsation Device with Integrated EKG System for Chronic Partial Circulator

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$1,583,137.00
Agency:
HHS
Principal Investigator:
Paul A. Spence – 502-640-3442
Abstract:
DESCRIPTION (provided by applicant): Heart failure (HF) remains one of the largest unsolved problems in health care today and continues to increase in incidence and cost ( 34.8 billion in US in 2008). Prognosis remains limited especially in patients with advanced heart failure. Transplantation is… More